FDA approved. New drug bulletin: Cisapride and Dornase alfa.
D000328:Adult; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D020117:Cisapride; D003550:Cystic Fibrosis; D003850:Deoxyribonuclease I / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D010353:Patient Education as Topic; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D010880:Piperidines; D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I; D020117:Cisapride